Genetic editing holds promise to treat incurable diseases, but the most popular method—CRISPR—sometimes does more harm than ...

Academic, industry, and FDA collaboration is key to personalized treatment manufacturing, says Aldevron’s Max Sellman at BPI this week.

CRISPR — short for clustered regularly interspaced short palindromic repeats — is a method of genetic editing that uses RNA ...